Chargement en cours...
Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradation
Leucine-rich repeat kinase 2 (LRRK2) kinase activity is increased in several pathogenic mutations, including the most common mutation, G2019S, and is known to play a role in Parkinson’s disease (PD) pathobiology. This has stimulated the development of potent, selective LRRK2 kinase inhibitors as one...
Enregistré dans:
| Publié dans: | Sci Rep |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5034242/ https://ncbi.nlm.nih.gov/pubmed/27658356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep33897 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|